Using MRI to make informed clinical decisions in multiple sclerosis care

Keyphrases

• Clinical Decisions 100%
• Multiple Sclerosis 100%
• Multiple Sclerosis Care 100%
• Treatment Monitoring 50%
• Clinical Evaluation 50%
• Patient's Will 50%
• Therapeutic Outcome 50%
• Disease-modifying Therapy 50%
• New Lesion 50%
• Stable Disease 50%
• Clinical Stability 50%
• T2-weighted Imaging (T2WI) 50%
• Therapy Selection 50%
• Long-term Prognosis 50%
• Inflammatory Diseases 50%
• Integral Component 50%
• Gadolinium-enhancing Lesions 50%
• Brain MRI 50%
• Lesion number 50%
• Subclinical Disease Activity 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Sclerosis 100%
• Clinical Trial 33%
• Anti-Inflammatory Drug 33%
• Disease Activity 33%
• Gadolinium 33%
• Inflammatory Disease 33%
• Diseases 33%

Neuroscience

• Magnetic Resonance Imaging 100%
• Multiple Sclerosis 100%
• Anti-Inflammatory 25%
• Magnetic Resonance Imaging of Brain 25%